SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-10-28BBNX8-KBeta Bionics Q3 2025 Financial Results and Guidance UpdateearningsHIGH
Beta Bionics, Inc. reported its financial results for the third quarter ended September 30, 2025, and raised its full-year guidance. The company achieved net sales of $27.3 million, a 63% increase compared to the same period in 2024. The Durable Medical Equipment (DME) channel contributed $21.0 million, up 45%, while t...
2025-10-28BLNE8-KBeeline Holdings, Inc. Enters into Settlement Agreement with Investorsfinancial obligation triggerMEDIUM
On October 22, 2025, Beeline Holdings, Inc. entered into a settlement agreement with District 2 Capital Fund LP and Bigger Capital Fund, LP. The agreement involves the redemption of Series E Preferred Stock held by the investors in exchange for cash payments totaling $2,000,000. The payments are contingent upon the eff...
2025-10-28BCSF8-KBain Capital Specialty Finance Q3 2025 Earnings AnnouncementearningsMEDIUM
Bain Capital Specialty Finance, Inc. (NYSE: BCSF) announced that it will release its financial results for the third quarter ended September 30, 2025, on November 10, 2025, after the market close. The company will host a conference call on November 11, 2025, at 8:30 a.m. Eastern Time to discuss the results. The press r...
2025-10-28BXP8-KBXP, Inc. Q3 2025 Financial Results and Development UpdateearningsMEDIUM
BXP, Inc. reported its financial results for the third quarter ended September 30, 2025. The company announced a net loss attributable to BXP, Inc. of $121.7 million, compared to a net income of $89.0 million in the previous quarter. Funds from Operations (FFO) attributable to BXP, Inc. were $276.7 million, with a dilu...
2025-10-28BFH8-KBread Financial Announces Private Offering of Senior Notes and Redemption of 2029 Notesdebt financingHIGH
Bread Financial Holdings, Inc. announced a private offering of $500 million in senior notes on October 28, 2025. The company intends to use the net proceeds from this offering, along with approximately $275 million in cash on hand, to redeem all of its outstanding 9.750% senior notes due 2029. The redemption is conditi...
2025-10-28AXTA8-KAxalta Coating Systems Q3 2025 Earnings ReleaseearningsHIGH
Axalta Coating Systems Ltd. reported its financial results for the third quarter ended September 30, 2025. The company achieved net sales of approximately $1.3 billion, with net income of $110 million, reflecting an 8.5% net income margin. Adjusted EBITDA reached a record $294 million, with a margin of 22.8%. Diluted E...
2025-10-28AUROW8-KAurora Innovation Q3 2025 Financial ResultsearningsMEDIUM
Aurora Innovation, Inc. announced its financial results for the quarter ended September 30, 2025. The company reported $1 million in revenue, driven by driverless and vehicle operator supervised commercial loads. The Aurora Driver achieved a record number of commercial miles, contributing to a 12% sequential increase i...
2025-10-28ATOM8-KAtomera Incorporated Q3 2025 Financial ResultsearningsMEDIUM
Atomera Incorporated announced its financial results for the third quarter ended September 30, 2025. The company reported a net loss of $5.6 million, or $0.17 per share, compared to a net loss of $4.6 million, or $0.17 per share, in the same period last year. Adjusted EBITDA for the quarter was a loss of $4.4 million, ...
2025-10-28APAM8-KArtisan Partners 3Q25 Earnings ReleaseearningsHIGH
Artisan Partners Asset Management Inc. reported its financial results for the third quarter of 2025, ending September 30. The company announced a quarterly dividend of $0.88 per share, representing approximately 80% of the cash generated during the quarter. Key highlights include a 7% increase in revenues compared to t...
2025-10-28ARQT8-KArcutis Biotherapeutics Q3 2025 Financial Results and Growth StrategyearningsHIGH
Arcutis Biotherapeutics, Inc. reported its financial results for the third quarter of 2025, highlighting significant growth in net product revenue for ZORYVE®, which reached $99.2 million, a 122% increase compared to the same period in 2024. The company also announced the FDA approval of ZORYVE cream 0.05% for treating...
2025-10-28RCUS8-KArcus Biosciences Reports Third-Quarter 2025 Financial Results and Pipeline UpdateearningsMEDIUM
Arcus Biosciences, Inc. reported its financial results for the third quarter ended September 30, 2025, and provided updates on its clinical-stage investigational molecules and discovery programs. The company highlighted the performance of casdatifan, a HIF-2a inhibitor, which demonstrated a median progression-free surv...
2025-10-28ANVS8-KAnnovis Bio, Inc. Announces Registered Direct Offeringequity offeringMEDIUM
On October 26, 2025, Annovis Bio, Inc. entered into a Securities Purchase Agreement with purchasers for a registered direct offering of 597,561 shares of common stock at $2.05 per share. Additionally, the company entered into Stock Subscription Agreements with two board members for the purchase of 1,073,171 shares. The...
2025-10-28AOUT8-K2025 Annual Meeting of Stockholders Resultsshareholder relatedMEDIUM
On October 27, 2025, American Outdoor Brands, Inc. held its 2025 Annual Meeting of Stockholders. The meeting included the election of six directors: Barry M. Monheit, Bradley T. Favreau, Mary E. Gallagher, Gregory J. Gluchowski, Jr., Luis G. Marconi, and Brian D. Murphy. Each director was elected with a majority of vot...
2025-10-28AAT8-KAmerican Assets Trust Q3 2025 Financial ResultsearningsMEDIUM
American Assets Trust, Inc. reported its financial results for the third quarter ended September 30, 2025. The company achieved net income available to common stockholders of $4.5 million, or $0.07 per diluted share, and Funds from Operations (FFO) of $0.49 per diluted share. The company also increased its 2025 FFO per...
2025-10-28AMTB8-KAmerant Bancorp Inc. Q3 2025 Financial ResultsearningsHIGH
Amerant Bancorp Inc. reported its financial results for the third quarter of 2025. The company posted a net income of $14.8 million, or $0.35 per diluted share, compared to $23.0 million, or $0.55 per diluted share, in the previous quarter. Total assets increased by 0.7% to $10.4 billion, while total gross loans decrea...
2025-10-28ALKS8-KAlkermes plc Q3 2025 Financial ResultsearningsHIGH
Alkermes plc reported its financial results for the third quarter of 2025, with total revenues of $394.2 million, a 4.3% increase compared to the same period in 2024. The company achieved a GAAP net income of $82.8 million, with diluted GAAP earnings per share of $0.49. Key drivers of revenue growth included strong per...
2025-10-28ALDX8-KAldeyra Therapeutics Announces Positive Phase 2 Clinical Trial Results and Pipeline Updatesoperation relatedMEDIUM
Aldeyra Therapeutics, Inc. announced positive results from a Phase 2 clinical trial in alcohol-associated hepatitis, demonstrating statistically significant improvement in liver function with their investigational drug ADX-629. The company also updated its RASP modulator product candidate pipeline, focusing on next-gen...
2025-10-28AKBA8-KAkebia Therapeutics Update on Vafseo for Non-Dialysis Patientsoperation relatedMEDIUM
On October 28, 2025, Akebia Therapeutics, Inc. announced that it will not initiate the VALOR clinical trial for the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease (CKD) not on dialysis. This decision follows a Type C meeting with the U.S. Food and Drug Administration (FDA), where t...
2025-10-28ATI8-KATI Inc. Q3 2025 Earnings ReleaseearningsHIGH
ATI Inc. reported its third quarter 2025 financial results, showcasing a 7% year-over-year increase in sales to $1.13 billion, driven by a 21% rise in aerospace & defense sales. Net income attributable to ATI rose 33% to $110 million, with earnings per share (EPS) of $0.78 compared to $0.57 in Q3 2024. Adjusted EPS was...
2025-10-28ABG8-KAsbury Automotive Group Q3 2025 Earnings ReleaseearningsHIGH
Asbury Automotive Group, Inc. reported record third quarter results for 2025, with all-time high revenue of $4.8 billion, a 13% increase from the previous year. Gross profit also reached a record $803 million, up 12%. The company achieved earnings per share (EPS) of $7.52, an 18% increase, and adjusted EPS of $7.17, up...
2025-10-28AWI8-KArmstrong World Industries Reports Strong Q3 2025 ResultsearningsHIGH
Armstrong World Industries, Inc. (AWI) announced its third-quarter 2025 financial results, reporting a 10% increase in net sales to $425 million. The company saw an 18% rise in Architectural Specialties net sales and a 6% increase in Mineral Fiber net sales. Operating income grew by 5%, and Adjusted EBITDA increased by...
2025-10-28ARCC8-KAres Capital Corporation Q3 2025 Financial Results and Dividend DeclarationearningsMEDIUM
Ares Capital Corporation announced its financial results for the third quarter ended September 30, 2025. The company reported GAAP net income of $404 million, or $0.57 per share, and Core EPS of $0.50. The company also declared a fourth quarter 2025 dividend of $0.48 per share, payable on December 30, 2025, to stockhol...
2025-10-28AQB8-KAquaBounty Technologies Issues $4 Million in Senior Notesdebt financingMEDIUM
On October 28, 2025, AquaBounty Technologies, Inc. entered into Note Purchase Agreements with certain investors, issuing $4 million in Senior Notes. The notes are unsecured, nonconvertible, and bear an 18% annual interest rate, with a maturity date of 18 months from closing. The proceeds are expected to be used for gen...
2025-10-28AQB8-KAquaBounty Technologies Q3 2025 Financial ResultsearningsMEDIUM
AquaBounty Technologies, Inc. announced its financial results for the third quarter ended September 30, 2025. The company reported a net loss of $1.4 million, an improvement from the $3.4 million net loss in the same period last year. The net loss included a non-cash asset impairment charge of $69 thousand related to e...
2025-10-28AIT8-KApplied Industrial Technologies Q1 2026 Earnings ReleaseearningsHIGH
Applied Industrial Technologies, Inc. reported its fiscal 2026 first quarter results, showing a 9.2% year-over-year increase in net sales to $1.2 billion. Net income rose to $100.8 million, or $2.63 per diluted share, an 11.4% increase from the previous year. The company also reported operating income of $129.0 million...